• Medientyp: E-Artikel
  • Titel: Severe Combined Immunodeficiency with De Novo Duchenne Muscular Dystrophy Mutation
  • Beteiligte: Shah, Kevin P.; Ramachandran, Vignesh; Nicholas, Sarah K.; Hanson, Imelda C.; Lotze, Timothy E.; Martinez, Caridad A.; Fishman, Douglas S.
  • Erschienen: Wiley, 2021
  • Erschienen in: JPGN Reports
  • Sprache: Englisch
  • DOI: 10.1097/pg9.0000000000000135
  • ISSN: 2691-171X
  • Schlagwörter: General Medicine
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:p>Both severe combined immunodeficiency (SCID) syndrome and Duchenne muscular dystrophy (DMD) are rare conditions. Patients with X-linked SCID have pathogenic variants of the <jats:italic toggle="yes">IL2RG</jats:italic> gene, resulting in defective cellular and humoral immunity. DMD is also an X-linked condition caused by a <jats:italic toggle="yes">dystrophin</jats:italic> gene mutation, causing progressive proximal muscle weakness. We present a patient diagnosed with SCID at birth who underwent matched unrelated donor bone marrow transplant (BMT). Several months after, he was noted to have persistently elevated aminotransferases. Despite a lack of clinical signs of graft versus host disease (GvHD), a liver biopsy revealed mild GvHD. Creatine kinase (CK) levels of &gt;19,000 U/L prompted evaluation for muscular dystrophies. Given BMT, genetic analysis was not an option. Muscle biopsy confirmed DMD. This case highlights the complexity of diagnosing and managing uncommon genetic conditions through a multidisciplinary team-based approach. This case is only the second reported case of SCID and DMD together.</jats:p>
  • Zugangsstatus: Freier Zugang